Skip to main content
Our diagnostic tests are game changers.

Our diagnostic tests are game changers


They’re everywhere around you, not only in emergency situations but also in your everyday life. For more than 60 years, our passionate team members have been committed to imagining, developing, manufacturing and providing life-saving diagnostic tests – to help make the world a healthier place.

Our diagnostic tests are game changers.

News

bioMérieux signed an Agreement to acquire Neoprospecta

bioMérieux, a world leader in the field of in vitro diagnostics, signed in November 2024 a Sale and Purchase Agreement (SPA) to acquire Neoprospecta. This company, based in Florianopolis, Brazil, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.

Swipe to discover more

  • Third-Quarter 2024 Business Review

    bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% at constant exchange rates and scope of consolidation.
    Read the press release
  • Advancing Antimicrobial Stewardship in Emergency Care: how diagnostics can change the game.

    Antimicrobial resistance (AMR) has been identified as an increasing threat to modern medicine, leading to higher treatment costs and increased morbidity and mortality.1 The misuse of broad-spectrum antibiotics is a major contributor to the rise of AMR — particularly in emergency care, where studies have estimated that 40% to 60% of antibiotics are inappropriately prescribed.2 To understand the cause of this disparity, it is important to provide context on the many unique facets of the emergency department, while exploring how comprehensive antimicrobial stewardship could improve prescribing practices.
    Read the blog post
  • Canada's First Center of Excellence in the Fight Against Antimicrobial Resistance

    On November 11, 2024, the Université de Sherbrooke (UdeS), the Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS) and bioMérieux, a world leader in the field of in vitro diagnostics, announce a three-year agreement to create a Canadian center of excellence dedicated to the fight against antimicrobial resistance and antibiotic stewardship.
    Read the news

VITEK® REVEAL™

The newest addition to our Sepsis Solution, VITEK® REVEAL™ offers rapid AST results to effectively and efficiently manage bloodstream infections.

VIDAS® KUBE™

VIDAS® KUBE™ is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE® FILMARRAY® TORCH

Syndromic infectious disease testing with BIOFIRE® FILMARRAY® TORCH is the fastest way to better results.

VITEK® MS PRIME

VITEK® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. 

BIOFIRE® SPOTFIRE® System

The BIOFIRE® SPOTFIRE® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.

BIOFIRE® SPOTFIRE® Respiratory Panels

Point-of-care respiratory testing solutions with SPOTFIRE Respiratory Panels offering rapid syndromic PCR tests for a range of common pathogens.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care and to fight AMR.

GENE-UP®

Our real-time PCR solution simplifies workflows, decreases cross-contamination risks, and gives you rapid results that speed up critical manufacturing decisions.

GENE-UP® TYPER

Move from test results to actionable insights and make impactful decisions within 2 hours from an isolated colony with GENE UP® TYPER. This real-time PCR assay utilizes probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence. 

VIDAS KUBE Product Image

VIDAS® KUBE™ Automated Food Pathogens Detection

 VIDAS® KUBE™’s adaptable automation helps your lab to be more productive, more accurate, and at the forefront of innovation—all-in-one simplifed platform.

TEMPO® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your laboratory.

ENDONEXT™ Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

BIOFIRE® Mycoplasma

BIOFIRE® Mycoplasma provides simple, accurate, and rapid in-house mycoplasma detection for use in testing raw materials, in-process samples, and final product release. We offer validation services designed to meet regulatory requirements—from documentation to comprehensive on-site support.

3P® ENTERPRISE

Bridging the gap between standard processes and automation, 3P® ENTERPRISE transforms the future of environmental monitoring in the pharmaceutical industry. From sampling to trending, take control with an end-to-end, fully digitalized and automated workflow. Increase efficiency and ensure your products are safe and compliant with an innovative environmental monitoring system

VITEK® MS PRIME

The VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing.